Sina Bahrpeyma
Väitöskirjatutkija
PhD student
Farmasian laitos, Terveystieteiden tiedekunta
sina.bahrpeyma@uef.fi
Sina Bahrpeyma graduated from Shiraz University of Medical Sciences (Pharm.D., 2013), and is completing his Doctoral Program in Drug Research (University of Eastern Finland, from January 2018) as well as being a visiting researcher at University of Helsinki. Currently, his research focuses on melanin and melanosome binding for ocular drug delivery with the aim of identifying a new therapy for untreated eye diseases such as Age-related Macular Degeneration (Dry-AMD).
Tutkimusryhmät
Julkaisut
4/4 kappaletta-
Liposomal sunitinib for ocular drug delivery: A potential treatment for choroidal neovascularization
Tavakoli, Shirin; Puranen, Jooseppi; Bahrpeyma, Sina; Lautala, Veera E.; Karumo, Suvi; Lajunen, Tatu; del Amo, Eva M.; Ruponen, Marika; Urtti, Arto. 2022. International journal of pharmaceutics. 620: -
Mechanisms of cellular retention of melanin bound drugs: Experiments and computational modeling
Bahrpeyma, Sina; Reinisalo, Mika; Hellinen, Laura; Auriola, Seppo; del Amo, Eva M; Urtti, Arto. 2022. Journal of controlled release. 348: 760-770 -
Microscale Thermophoresis as a Screening Tool to Predict Melanin Binding of Drugs
Hellinen, Laura; Bahrpeyma, Sina; Rimpelä, Anna-Kaisa; Hagström, Marja; Reinisalo, Mika; Urtti, Arto. 2020. Pharmaceutics. 12: 554 -
Release of functional dexamethasone by intracellular enzymes: A modular peptide-based strategy for ocular drug delivery
Bhattacharya, Madhushree; Sadeghi, Amir; Sarkhel, Sanjay; Hagström, Marja; Bahrpeyma, Sina; Toropainen, Elisa; Auriola, Seppo; Urtti, Arto. 2020. Journal of controlled release. 327: 584-594